These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1004 related items for PubMed ID: 21397634
1. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Réus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, Souza CT, Quevedo J. Behav Brain Res; 2011 Aug 01; 221(1):166-71. PubMed ID: 21397634 [Abstract] [Full Text] [Related]
7. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats. Itoh T, Tokumura M, Abe K. Eur J Pharmacol; 2004 Sep 13; 498(1-3):135-42. PubMed ID: 15363987 [Abstract] [Full Text] [Related]
10. Effect of co-administration of memantine and sertraline on the antidepressant-like activity and brain-derived neurotrophic factor (BDNF) levels in the rat brain. Amidfar M, Réus GZ, Quevedo J, Kim YK, Arbabi M. Brain Res Bull; 2017 Jan 13; 128():29-33. PubMed ID: 27825855 [Abstract] [Full Text] [Related]
13. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats. Butterweck V, Winterhoff H, Herkenham M. Mol Psychiatry; 2001 Sep 13; 6(5):547-64. PubMed ID: 11526469 [Abstract] [Full Text] [Related]
14. Effects of combined treatment with imipramine and metyrapone in the forced swimming test in rats. Behavioral and pharmacokinetic studies. Rogóz Z, Skuza G, Wójcikowski J, Daniel WA. Pol J Pharmacol; 2003 Sep 13; 55(6):993-9. PubMed ID: 14730094 [Abstract] [Full Text] [Related]
16. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Wesołowska A, Nikiforuk A. Neuropharmacology; 2007 Apr 13; 52(5):1274-83. PubMed ID: 17320917 [Abstract] [Full Text] [Related]
17. The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes. Tamburella A, Micale V, Leggio GM, Drago F. Eur Neuropsychopharmacol; 2010 Oct 13; 20(10):704-13. PubMed ID: 20537869 [Abstract] [Full Text] [Related]
18. Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance. Walker AJ, Foley BM, Sutor SL, McGillivray JA, Frye MA, Tye SJ. Behav Brain Res; 2015 Oct 15; 293():198-202. PubMed ID: 26209292 [Abstract] [Full Text] [Related]
19. Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-D-aspartate receptor antagonist neramexane in mice. Kos T, Legutko B, Danysz W, Samoriski G, Popik P. J Pharmacol Exp Ther; 2006 Sep 15; 318(3):1128-36. PubMed ID: 16740621 [Abstract] [Full Text] [Related]
20. Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. Larsen MH, Mikkelsen JD, Hay-Schmidt A, Sandi C. J Psychiatr Res; 2010 Oct 15; 44(13):808-16. PubMed ID: 20172535 [Abstract] [Full Text] [Related] Page: [Next] [New Search]